Stocks and Investing Stocks and Investing
Fri, July 16, 2021

Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $280 on, Jul 16th, 2021


Published on 2024-10-27 17:13:22 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $278 to $280 on, Jul 16th, 2021.

Matthew has made no other calls on AMGN in the last 4 months.



There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $238 on, Monday, June 7th, 2021
  • Kennen MacKay of "RBC Capital" Maintained at Hold with Decreased Target to $217 on, Wednesday, April 28th, 2021


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $277 on, Monday, June 7th, 2021
  • Steve Chesney of "Atlantic Equities" Downgraded from Hold to Sell and Held Target at $200 on, Wednesday, April 28th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $259 on, Wednesday, April 28th, 2021

Contributing Sources